Logo Unión Europea

Lapatinib Desfluoro Impurity

Lapatinib Desfluoro Impurity

GA01201 - 95%

In stock
Delivery: 3 to 5 working days
Others quantities on request


  • Description


    Lapatinib is an orally active drug for breast cancer and other solid tumours. It is a dual tyrosine kinase inhibitor which interrupts the HER2/neu and epidermal growth factor receptor (EGFR) pathways. It is used in combination therapy for HER2-positive breast cancer.

    We have successfully synthesized standards of the Lapatinib. This will be of interest to pharmaceutical companies and analytical labs.

  • Additional information
    Packing Unit

    50 mg, 100 mg